MapLight Therapeutics (MPLT) Retained Earnings (2024 - 2025)
MapLight Therapeutics recorded quarterly Retained Earnings of -$228000.0 in Q4 2025, up 99.92% quarter-over-quarter from -$281.0 million in Q3 2025, and up 99.89% year-over-year from -$114065.2 in Q4 2024.
MapLight Therapeutics' Retained Earnings history runs 2 years deep, the most recent figure standing at -$228000.0 for Q4 2025.
- In Q4 2025, Retained Earnings rose 99.89% year-over-year to -$228000.0; the TTM figure through Dec 2025 stood at -$228000.0 (up 99.89% YoY), while the FY2025 annual figure was -$228000.0, up 99.89% from the prior year.
- Retained Earnings came in at -$228000.0 for Q4 2025 at MapLight Therapeutics, up from -$281.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$228000.0 in Q4 2025 to a low of -$281.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | MapLight Therapeutics | 254.43 Mn | 254.43 Mn | - | -228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -228,000.00 |
| Sep 30, 2025 | -281.00 Mn |
| Dec 31, 2024 | -199.37 Mn |